ABUS Competitors & Alternatives
Compare Arbutus Biopharma Corp with similar stocks in the same industry
Biotechnology
ABUS
Main Stock$4.45
Tradestie Score
61
Market Cap
$879.90M
P/E Ratio
5.4
Revenue Growth
100.5%
Analyst Upside
+13.9%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCS
Oculis Holding AG Ordinary shares
|
$11.72
|
$910.64M | - | 57 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$25.00
|
$906.29M | - | 55 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$36.60
|
$903.54M | - | 48 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$83.40
|
$900.91M | - | 54 | Compare |
|
GERN
Geron Corp
|
$1.35
|
$899.60M | - | 61 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$59.43
|
$894.30M | - | 58 | Compare |
|
EYPT
EyePoint Pharmaceuticals, Inc. Common Stock
|
$14.38
|
$890.20M | - | 58 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$28.39
|
$887.30M | - | 64 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$10.86
|
$871.90M | - | 54 | Compare |
|
DNA
Ginkgo Bioworks Holdings, Inc.
|
$8.86
|
$868.46M | - | 56 | Compare |
More ABUS Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry